Schwarz, L. J., Fox, E. M., Balko, J. M., Garrett, J. T., Kuba, M. G., Estrada, M. V., . . . Arteaga, C. L. (2014). LYN-activating mutations mediate antiestrogen resistance in estrogen receptor–positive breast cancer. J Clin Invest.
Chicago Style CitationSchwarz, Luis J., et al. "LYN-activating Mutations Mediate Antiestrogen Resistance in Estrogen Receptor–positive Breast Cancer." J Clin Invest 2014.
Cita MLASchwarz, Luis J., et al. "LYN-activating Mutations Mediate Antiestrogen Resistance in Estrogen Receptor–positive Breast Cancer." J Clin Invest 2014.
Atenció: Aquestes cites poden no estar 100% correctes.